Printer-friendly version

GenoLogics is a privately-held, venture capital backed company founded in 2001. Since 2005, GenoLogics has attracted more than $17.5 million in investment from leading venture capital funds and strategic partners. 

GenoLogics' major investors include OVP Venture Partners, Yaletown Venture Partners, Growthworks Capital, and Don Listwin, Founder & Chairman of the Canary Foundation - North America's leading foundation committed to the early detection of cancer. GenoLogics also benefits from the involvement of several of North America's most accomplished life science and technology executives as angel investors.

Attracting strong support from investors in financing rounds completed in early-2005, late-2006, and late-2008, GenoLogics continues to accelerate its product development, sales and marketing initiatives. 

Over its 22 year history as an early-stage venture firm, OVP has been funding industry leading start-ups in the Pacific Northwest. The firm currently has US $500 million in capital under management.
www.ovp.com

Based in Vancouver, B.C., Yaletown Venture Partners is a venture capital firm that invests time, expertise, and money in seed and early-stage technology companies. Backed by several of Canada’s largest institutional investors, Yaletown focuses on Western Canada’s information technology and energy technology clusters.
www.yaletown.com

GrowthWorks refers to affiliates of GrowthWorks Ltd. recognized leader in the Canadian venture capital industry, specializing in the management and growth of regionally based venture capital funds. GrowthWorks has combined assets under management of more than $800 million.
www.growthworks.ca